Atlas Venture
Venture capital · Cambridge, Massachusetts, United States
Portfolio collected from the firm’s website, last checked Oct 25, 2026.Raises and exits come from each company’s own SEC and company records.
56Deep-tech portfolio33 active
23Portfolio exitsAcquired or listed
3Raises, 12 monthsLatest: Gossamer Bio
80Co-investorsShare a portfolio company
Portfolio · 56 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Caldera Therapeutics | Biotech | Active | Jan 21, 2026 | $37.5M |
| TRIANA Biomedicines | Biotech | Active | Dec 4, 2025 | $170.9M |
| Affinia Therapeutics | Biotech | Active | Oct 14, 2025 | $170.1M |
| Therini Bio | Biotech | Active | Sep 8, 2025 | $29.0M |
| Ikena Oncology | Biotech | Active | Jul 18, 2025 | $42.6M |
| Renasant Bio | Biotech | Active | Jul 14, 2025 | $55.5M |
| Antares Therapeutics | Biotech | Active | May 15, 2025 | $70.0M |
| Judo Bio | Biotech | Active | Aug 16, 2024 | $50.0M |
| Comanche Biopharma | Biotech | Active | Jan 17, 2024 | $73.6M |
| Remix Therapeutics | Biotech | Active | Jan 4, 2024 | $13.7M |
| Kinaset Therapeutics | Biotech | Active | Jul 17, 2023 | $30.0M |
| Matchpoint Therapeutics | Biotech | Active | Oct 17, 2022 | $42.0M |
| Korro Bio | Biotech | Active | Jun 7, 2019 | $4.0M |
| IFM Therapeutics | Biotech | Active | Jun 28, 2016 | $17.1M |
| AAVantgarde Bio | Biotech | Active | — | — |
| Accent Therapeutics | Biotech | Active | — | — |
| Akeso | Biotech | Active | — | — |
| Cartography Biosciences | Biotech | Active | — | — |
| Cogent Biosciences | Biotech | Active | — | — |
| Diagonal Therapeutics | Biotech | Active | — | — |
| Disc Medicine | Biotech | Active | — | — |
| Ethyreal Bio | Biotech | Active | — | — |
| HotSpot Therapeutics | Biotech | Active | — | — |
| K36 Therapeutics | Biotech | Active | — | — |
| Kymera Therapeutics | Biotech | Active | — | — |
| nChroma Bio | Biotech | Active | — | — |
| Nimbus Therapeutics | Biotech | Active | — | — |
| Pheon Therapeutics | Biotech | Active | — | — |
| Rectify | Biotech | Active | — | — |
| Replimune | Biotech | Active | — | — |
| Trace Neuroscience | Biotech | Active | — | — |
| Triveni Bio | Biotech | Active | — | — |
| Vima Therapeutics | Biotech | Active | — | — |
| Gossamer Bio | Biotech | Public | Sep 4, 2026 | $728.1M |
| Voyager Therapeutics | Biotech | Public | Jan 17, 2024 | $119.0M |
| Vigil Neuroscience | Biotech | Acquired | Aug 29, 2022 | $195.0M |
| Entrada Therapeutics | Biotech | Public | Apr 13, 2021 | $150.9M |
| Imago BioSciences | Biotech | Acquired | Nov 20, 2020 | $105.8M |
| Elevation Oncology | Biotech | Acquired | Nov 18, 2020 | $70.5M |
| Decibel Therapeutics | Biotech | Acquired | Nov 12, 2020 | $62.8M |
| Dyne Therapeutics | Biotech | Public | Aug 14, 2020 | $115.7M |
| iTeos Therapeutics | Biotech | Acquired | Apr 9, 2020 | $125.4M |
| Generation Bio | Biotech | Acquired | Jan 14, 2020 | $211.8M |
| Synlogic | Biotech | Acquired | Jun 18, 2019 | $140.5M |
| Akero Therapeutics | Biotech | Acquired | Dec 18, 2018 | $45.5M |
| Obsidian Therapeutics | Biotech | Public | Dec 8, 2017 | $32.4M |
| Mersana Therapeutics | Biotech | Acquired | Jun 24, 2016 | $69.2M |
| Intellia Therapeutics | Biotech | Public | Sep 3, 2015 | $70.0M |
| Syndax Pharmaceuticals | Biotech | Public | Aug 28, 2015 | $139.5M |
| Ra Pharmaceuticals | Biotech | Acquired | Jul 23, 2015 | $39.6M |
| Blueprint Medicines | Biotech | Acquired | Nov 20, 2014 | $73.2M |
| Day One Biopharmaceuticals | Biotech | Acquired | — | — |
| Kailera Therapeutics | Biotech | Public | — | — |
| Mariana Oncology | Biotech | Acquired | — | — |
| Q32 Bio | Biotech | Public | — | — |
| Sionna Therapeutics | Biotech | Public | — | — |
Peer ranks
Portfolio size#5
Portfolio exits#4
Raises, 12 months#5
Co-investors#4
Co-investors
- RA CapitalVenture capital11 shared
- Third Rock VenturesVenture capital7 shared
- Biotechnology Value FundVenture capital6 shared
- Perceptive AdvisorsVenture capital4 shared
- Alexandria Venture InvestmentsVenture capital3 shared
- ARCH VentureVenture capital3 shared
- EcoR1 CapitalVenture capital3 shared
- Foresite CapitalVenture capital3 shared
- GenzymeVenture capital3 shared
- LifeSci Venture PartnersVenture capital3 shared
Sectors
- Biotech56
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.